Altimmune, Inc. - stock earnings
ALT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -20.7 million USD | 362000 USD |
| 2023Q2 | -16.1 million USD | 6000 USD |
| 2023Q1 | -18.4 million USD | 21000 USD |
| 2022Q4 | -20.2 million USD | -110000 USD |
| 2022Q3 | -23.5 million USD | 2000 USD |
| 2022Q2 | -19.8 million USD | 8000 USD |
| 2022Q1 | -19.4 million USD | 32000 USD |
| 2021Q4 | -23.9 million USD | 3.3 million USD |
| 2021Q3 | -33.5 million USD | 157559 USD |
| 2021Q2 | -24.8 million USD | 137623 USD |
| 2021Q1 | -14.9 million USD | 837516 USD |
| 2020Q4 | -10.6 million USD | 2.3 million USD |
| 2020Q3 | -17.8 million USD | 2.9 million USD |
| 2020Q2 | -16.8 million USD | 721636 USD |
| 2020Q1 | -3.9 million USD | 2.2 million USD |
| 2019Q4 | -4.1 million USD | 575801 USD |
| 2019Q3 | -10.9 million USD | 643978 USD |
| 2019Q2 | -3.4 million USD | 1.6 million USD |
| 2019Q1 | -24.5 million USD | 2.6 million USD |
| 2018Q4 | -24.5 million USD | 2.6 million USD |
| 2018Q3 | -2.4 million USD | 2.6 million USD |
| 2018Q2 | -9.1 million USD | 2.4 million USD |
| 2018Q1 | -8.8 million USD | 2.8 million USD |
| 2017Q4 | -8.8 million USD | 2.8 million USD |
| 2017Q3 | -29.9 million USD | 4.6 million USD |
| 2017Q2 | -3.1 million USD | 4938 USD |
| 2017Q1 | -2.2 million USD | 804071 USD |
| 2016Q4 | 77.8 million USD | 1.1 million USD |
| 2016Q3 | 109.2 million USD | 993885 USD |
| 2016Q2 | 8.0 million USD | 2.1 million USD |
| 2016Q1 | -1.2 million USD | 1.0 million USD |
| 2015Q4 | -1.2 million USD | 1.3 million USD |
| 2015Q3 | -1.3 million USD | 1.2 million USD |
| 2015Q2 | -2.3 million USD | 1.1 million USD |
| 2015Q1 | 1.5 million USD | 7.1 million USD |
| 2014Q4 | -2.6 million USD | 1.8 million USD |
| 2014Q3 | -4.6 million USD | 962451 USD |
| 2014Q2 | -439120 USD | 3.7 million USD |
| 2014Q1 | -2.3 million USD | 3.7 million USD |
| 2013Q4 | -4.4 million USD | 3.7 million USD |
| 2013Q3 | -3.9 million USD | 3.5 million USD |
| 2013Q2 | -1.2 million USD | 4.3 million USD |
| 2013Q1 | -2.1 million USD | 6.5 million USD |
| 2012Q4 | -1.3 million USD | 6.0 million USD |
| 2012Q3 | -213936 USD | 6.7 million USD |
| 2012Q2 | -756543 USD | 6.3 million USD |
| 2012Q1 | -2.7 million USD | 6.1 million USD |
| 2011Q4 | 749193 USD | 6.2 million USD |
| 2011Q3 | -33496 USD | 5.3 million USD |
| 2011Q2 | -2.4 million USD | 6.4 million USD |
| 2011Q1 | -2.1 million USD | 6.3 million USD |
| 2010Q4 | -16.2 million USD | 6.9 million USD |
| 2010Q3 | -4.3 million USD | 6.2 million USD |
| 2010Q2 | -6.4 million USD | 4.8 million USD |
| 2010Q1 | -7.9 million USD | 3.1 million USD |
| 2009Q4 | -5.7 million USD | 7.1 million USD |
| 2009Q3 | -14.0 million USD | 6.8 million USD |
| 2009Q2 | -6.6 million USD | 8.1 million USD |
| 2009Q1 | -6.0 million USD | 5.5 million USD |
| 2008Q4 | -5.2 million USD | 5.5 million USD |
| 2008Q3 | -4.3 million USD | 10.7 million USD |
| 2008Q2 | -21.9 million USD | 10.9 million USD |
| 2008Q1 | -5.0 million USD | 5.8 million USD |
| 2007Q4 | -5.1 million USD | 6.0 million USD |
| 2007Q3 | -316914 USD | 3.4 million USD |
| 2007Q2 | -211276 USD | 2.2 million USD |
| 2007Q1 | 226849 USD | 492156 USD |
| 2006Q4 | 226849 USD | 492156 USD |
| 2006Q3 | 301141 USD | 484485 USD |
| 2006Q2 | 283894 USD | 466048 USD |
| 2006Q1 | 204450 USD | 405023 USD |
| 2005Q4 | 133319 USD | 379813 USD |
| 2005Q3 | 146476 USD | 206261 USD |
ALT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -78.5 million USD | 279000 USD |
| 2022 | -84.7 million USD | -68000 USD |
| 2021 | -96.2 million USD | 4.4 million USD |
| 2020 | -49.0 million USD | 8.2 million USD |
| 2019 | -20.5 million USD | 5.8 million USD |
| 2018 | -39.2 million USD | 10.3 million USD |
| 2017 | -46.4 million USD | 41503 USD |
| 2016 | 193.9 million USD | 5.2 million USD |
| 2015 | -3.4 million USD | 10.6 million USD |
| 2014 | -10.0 million USD | 10.2 million USD |
| 2013 | -11.7 million USD | 17.9 million USD |
| 2012 | -4.9 million USD | 25.2 million USD |
| 2011 | -3.8 million USD | 24.3 million USD |
| 2010 | -34.8 million USD | 21.0 million USD |
| 2009 | -32.3 million USD | 27.5 million USD |
| 2008 | -36.4 million USD | 32.9 million USD |
| 2007 | -13.6 million USD | 14.6 million USD |
| 2006 | 1.0 million USD | 1.8 million USD |
| 2005 | 277295 USD | 586074 USD |
ALT
Price: $7.19
52 week price:
Earnings Per Share: -1.66 USD
P/E Ratio: -6.75
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 680703
Ebitda: -31.4 millionMarket Capitalization: 567.9 million